35.90 USD
▲-0.02+5.71%
盘后 33.50 -1.35%
2026-08-03
市值
$4.57B
市盈率
—
EPS
-67.09
股息率
—
52 周区间
24.51 – 34.93
成交量
357.08K
Beta
—
目标价
41.75
52W 低 24.5152W 高 34.93
价格走势
公司简介
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon discovery platform, targeting proteins that are traditionally considered undruggable. Its pipeline includes functional inhibitors of intracellular protein-protein interactions, targeted protein degraders, and targeted radiopharmaceuticals, with a lead clinical program, FOG-001, that acts as a TCF-blocking beta-ca...